(Reuters) - Private equity firm KKR & Co has agreed to acquire a stake in Cotiviti from private-equity manager Veritas Capital, the healthcare technology firm said on Wednesday.
KKR was a leading contender to buy a 50% stake in Cotiviti and a transaction would value it between $10 billion and $11 billion, sources familiar with the matter had told Reuters earlier on Wednesday.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)